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Background: Associations between major depressive disorder (MDD) and coronary heart
disease (CHD) have been established, and these associations increase risk of future
morbidity and mortality. Prior research has been carried out in high-income countries. Here
we examine associations between the mood and anxiety disorders, and CHD in a large
cohort at baseline from Brazil, a country facing a variety of challenges that may affect these
associations.
Methods: Participants included 15,105 civil servants aged 35 to 74 at baseline (2008–2010)
from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). CHD (N = 721) included
self-reported angina pectoris (n = 305), myocardial infarction (n = 259) and coronary
revascularization (n = 239). Hierarchical logistic regression analyses were conducted to
estimate odds ratios and conﬁdence intervals.
Results: Major ﬁndings indicate that comorbid MDD and anxiety disorders (n = 434)
are associated with a threefold increase in CHD, MDD alone (n = 170) with a twofold
increase in CHD, while generalized anxiety disorder alone (n = 1,394) and mixed anxiety
and depression disorder (n = 1,844) – symptoms present, but diagnostic threshold not
reached – are associatedwith a 1.5-fold increase in CHD, after full adjustment for covariates.
Conclusion: The association with CHD is greatest in those with psychiatric comorbidity,
while associations were also observed in MDD and generalized anxiety disorder without
comorbidity. While ﬁndings are limited by the cross-sectional design of the study, given
the known risks associated with comorbidity of the mood and anxiety disorders with CHD,
ﬁndings reinforce the importance of comprehensive health assessment in Brazil.
Keywords: major depressive disorder, anxiety disorders, disorder comorbidity, coronary heart disease
INTRODUCTION
Major depressive disorder (MDD) and coronary heart disease
(CHD) are leading burdens of disease and the relationship between
these disorders is bidirectional (Nemeroff and Goldschmidt-
Clermont, 2012; Ramasubbu et al., 2012a; Stapelberg et al., 2012;
Lichtman et al., 2014): many patients experience depression
decades before CHD is manifest, while MDD in patients with
CHD is associated with increased morbidity and mortality. How-
ever, it remains unclear whether MDD, anxiety disorder or their
comorbidity are most associated with CHD. Research has begun
to highlight associations between the anxiety disorders and CHD
(Tully and Cosh, 2013; Tully et al., 2013). A study on participants
recruited for the Netherlands Study of Depression and Anxiety
(N = 2807) reported that persons with current anxiety disorders
with or without depression have a threefold increased prevalence
of CHD, while no associations were observed for those with
depressive disorders alone, or for depressive and anxiety disorders
in remission (Vogelzangs et al., 2010). Research has been restricted
to high-income countries including Australia, Canada, Denmark,
Finland, Netherlands, UK, and USA (Vogelzangs et al., 2010; Tully
andCosh, 2013), highlighting a need for research in low tomiddle-
income countries. Given the lack of data on the associations
between common mental disorders (CMD), speciﬁc mood and
anxiety disorders, and CHD in Brazil, an upper-middle-income
country, the present study sought to address this need.
It is unclear whether the associations between the mood and
anxiety disorders, and CHD parallel those or differ from the
ﬁndings reported in developed countries such as the Nether-
lands (e.g., Vogelzangs et al., 2010). Research has demonstrated
that Brazil is characterized by higher rates of mental disorders
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(Andrade et al., 2012), while rates of antidepressant use (Brunoni
et al., 2013) are lower than high-income countries. Brazil faces
signiﬁcant social challenges that may contribute to psycholog-
ical distress (de Jesus Mari, 2014), which may affect observed
associations. For example, Brazil has one of the highest lev-
els of income inequality in the world and recent data from this
country (Filho et al., 2013) indicate that this inequality is asso-
ciated with mental disorders, especially depression. The authors
argued that inequality is associated with adverse social compar-
isons, leading topsychological distress, and increases in disease and
mortality, consistent with the‘relative income hypothesis’ (Wilkin-
son, 2002). Income inequality is likely one of many psychosocial
stressors that may affect the associations between the mood and
anxiety disorders and CHD in Brazil. We hypothesized a relation-
ship between CMD and CHD, and predicted that the prevalence
of CHD would be most robust in those with comorbid MDD
and anxiety disorders after controlling for relevant confounding
factors including antidepressant medications, socio-demographic
issues, physical inactivity, obesity and smoking, as well as risk
factors including dyslipidemia, hypertension, and diabetes. Here
we deﬁned CHD as participants reporting a medical history of
stable angina pectoris, myocardial infarction (MI) or coronary
revascularisation.
MATERIALS AND METHODS
PARTICIPANTS
ELSA-Brasil is a cohort of 15,105 civil servants aged 35 to 74
enrolled between August, 2008 and December, 2010 at six cities
(Belo Horizonte, Porto Alegre, Rio de Janeiro, Salvador, Sao Paulo,
and Vitoria) designed to investigate the relationship between car-
diovascular diseases and diabetes, their social determinants and
risk factors. The study design and sampling procedures of ELSA-
Brasil have been reported previously (Aquino et al., 2012; Schmidt
et al., 2014). Exclusion criteria comprised current or recent preg-
nancy (within 4 months of ﬁrst interview), intention to quit
working at the institution in the near future, severe cognitive or
communication impairment, and if retired, residence outside of a
study centre’s metropolitan area.
ETHICS STATEMENT
The ethics committees of the participating universities approved
the research protocol. All participants provided written informed
consent after a complete description of the study. The study design
and sampling procedures of ELSA-Brasil have been reported
previously (Aquino et al., 2012; Schmidt et al., 2014).
PSYCHIATRIC EVALUATION
Mental disorders were determined by trained interviewers using
the Portuguese version (Nunes et al., 2012) of the Clinical Inter-
view Schedule-Revised (CIS-R; Lewis et al., 1992). This is a
structured interview used for diagnosis of current, common, non-
psychotic psychiatric conditions in the community. The complete
CIS-R version was applied; CMDs were deﬁned as participants
with CIS-R scores ≥12. The following ICD-10 categories were also
determined: MDD, agoraphobia, social phobia, speciﬁc phobia,
generalized anxiety disorder (GAD), panic disorder, social anxiety
disorder, andmixed anxiety anddepressive disorder (MADD). The
ICD-10 refers to the 10th revision of the International Statistical
Classiﬁcation of Diseases and Related Health Problems, a medical
classiﬁcation list by the World Health Organization. These diag-
nostic groupings were then reduced to six categories: MDD, GAD,
all phobias, panic disorder, a comorbid group comprised of partic-
ipants with MDD and any anxiety disorder, and MADD. The latter
two categories are distinct; the former comprises participants that
meet criteria for both MDD and any anxiety disorder, while the
latter comprises participants who display symptoms of both anxi-
ety and depression, but do not meet the criteria of either diagnosis
separately.
CORONARY HEART DISEASE ASSESSMENT
Coronary heart disease included participants who reported a
medical diagnosis of stable angina pectoris, MI or coronary revas-
cularization determined through questionnaire- and intensive
interview-based assessment focusing on medical history.
COVARIATES
Sociodemographic information included age, sex, years of edu-
cation (less than high-school, high-school, university) and race
(white, mixed, black, Asiatic, indigenous). Lifestyle and behav-
ioral characteristics included smoking status (never, past/current),
physical activity (measured with the International Physical Activ-
ity Questionnaire (Craig et al., 2003) and categorized according
to low, moderate, or high activity based on scoring guidelines:
http://www.ipaq.ki.se/scoring.pdf) and body mass index (BMI;
weight in kilograms divided by height in meters squared). Estab-
lished risk factors for CHD were also considered in analysis; these
included hypertension, diabetes mellitus (DM), and dyslipidemia.
Hypertensionwas deﬁned as systolic blood pressure≥140mmHg,
or diastolic blood pressure ≥90 mm Hg, or use of antihypertensive
medications. Resting blood pressure was measured three times in
the seated position after 5 min rest, and the average of the sec-
ond and third measurements were used in analyses. Diabetes was
deﬁned as self-reported or fasting blood glucose ≥126 mg/dL or 2-
h oral glucose tolerance test ≥200 mg/dL or glycated hemoglobin
≥6.5%. Dyslipidemiawas deﬁned as LDL-cholesterol≥130mg/dL
or use of lipid reductor.We identiﬁed antihypertensive treatments,
medications for diabetes, and antidepressants on the basis of
prescription and over-the-counter drugs in the past 2 weeks deter-
mined through pill bottle review. Antidepressant use was added
as a covariate considering that antidepressant medications may
also contribute to morbidity and mortality (Smoller et al., 2009;
Whang et al., 2009; Hamer et al., 2011).
STATISTICAL ANALYSIS
Statistical analysis was conducted using IBM SPSS Statistics Ver-
sion 21. Participant characteristics were examined using indepen-
dent samples t-tests and one-way analyses of variance (ANOVA)
for contrasts involving continuous dependent measures, and χ2
statistics for categorical variables. Tukey’s HSD was used to cor-
rect for multiple comparisons and aid interpretation of ANOVA’s,
while standardized residuals (z-scores) were used to help interpret
chi-square tests on larger contingency tables (as per Field, 2013).
A series of logistic regression analyses were then used to estimate
the odds ratios and 95% conﬁdence intervals for the association
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between CMD and CHD, before and after adjustment for covari-
ates. These initial analyses were followed up by sensitivity analysis
on the speciﬁc mental disorder groupings. Unadjusted analyses
(Model 1) were conducted on CMD, as well as speciﬁc mental
disorder groupings, with no other predictors. Adjusted multivari-
ate analyses (Model 2) involved hierarchical (blockwise) logistic
regression analysis on a priori selected covariates (as described
in previous section). Each covariate grouping (i.e., sociode-
mographic information, lifestyle/behavioral characteristics, risk
factors, and medications) was entered into a successive block;
mental disorders were entered into the ﬁnal block. Variables in
each block were entered simultaneously using the forced entry
method to assess the independent contribution of each predic-
tor over and above all other predictors entered in the same block.
Finally, additional sensitivity analyseswere conducted for subtypes
of CHD including stable angina pectoris, MI, and coronary revas-
cularisation to determine the consistency of associations across
these distinct categories of CHD. Again, these analyses involved
hierarchical (blockwise) logistic regression analysis adjusting for
covariate groupings (as per Model 2).
RESULTS
PARTICIPANT CHARACTERISTICS
Table 1 summarizes participant characteristics by CHD status.
Compared to participants without CHD (n = 14,366), those with
CHD (n = 721) were older, black, less educated, and male. They
engaged in less physical activity, were heavier, more likely to have
smoked (or to be a smoker), haveDM,hypertension, dyslipidemia,
or a CMDand to bemedicatedwith antidepressants.When group-
ings of mental disorders were examined, comorbid MDD and
anxiety was signiﬁcantly associated with CHD. Table 2 presents
participant characteristics according to whether or not partici-
pantswere identiﬁed as having aCMD.Compared to thosewithout
CMD (n = 11,058), participants with CMD (n = 4,036) were
more likely to be younger, less educated, and female. They were
less likely to be white, engaged in less physical activity, and were
heavier. They were more likely to have smoked (or to be a smoker),
to have DM or CHD, and to be medicated with antidepressants.
Table 3 provides ﬁner grained detail on participant characteristics
by speciﬁc mental disorder groupings including MDD (n = 179),
GAD (n = 1,458), phobias (n = 156), PD (n = 74), MADD
(n = 1914), comorbid MDD, and anxiety disorders (n = 451)
as well as controls.
ASSOCIATION BETWEEN MENTAL DISORDERS AND CHD
Table 4 describes the results of unadjusted and fully adjusted
logistic regression analyses assessing the association of CMD
as well as mental disorder groupings relative to those without
mental disorders. Model 1 provides the results of unadjusted
analyses conducted for CMD [model χ2(1) = 26.53, p = 0.001]
and speciﬁc mental disorder groupings [model χ2(6) = 32.16,
p < 0.001]. Model 2 refers to adjusted analyses for CMD [model
χ2 (17) = 708.25, p< 0.001; block χ2 (1) = 43.76, p< 0.001] and
mental disorder groupings [model χ2 (22) = 686.87, p < 0.001;
block χ2 (6) = 43.06, p < 0.001]. In the fully adjusted model
(model 2), the odds of CHD were most robust for those
with comorbid MDD and anxiety disorders (OR: 2.99, 95%
CI = 2.10–4.28), followed by those participants with MDD (OR:
2.14, 95% CI = 1.17–3.95), participants with GAD (OR: 1.41,
95% CI = 1.07–1.85), and participants that displayed symp-
toms of both anxiety and depression, but did not meet the
criteria of either diagnosis separately (MADD; OR: 1.53, 95%
CI = 1.20–1.94). Participants with comorbid MDD and anxi-
ety disorders display a greater association with CHD, than GAD
and MADD (i.e., conﬁdence intervals do not overlap), but
not MDD.
ASSOCIATION BETWEEN MENTAL DISORDERS AND CHD SUBTYPES
Table 5 reports results for additional sensitivity analyses on stable
angina pectoris, MI, and coronary revascularization.
For angina, there was a signiﬁcant association with CMD
[model χ2(17) = 199.51, p < 0.001; block χ2(1) = 35.49,
p < 0.001], and mental disorder groupings [model χ2(22) =
189.43, p< 0.001; blockχ2(6)= 27.57, p< 0.001] after full adjust-
ment. Results indicate that MDD, GAD, MADD, and comorbid
MDD and anxiety disorders are associated with angina; odds were
most robust for the comorbid group (OR: 2.98, 95% CI = 1.83–
4.83), followed by MDD (OR: 2.87, 95% CI = 1.36–6.04), GAD
(OR: 1.58, 95% CI = 1.09–2.31), and MADD (OR: 1.64, 95%
CI = 1.18–2.29). It should be noted that conﬁdence intervals are
overlapping for each of these groups, so we cannot say with cer-
tainty that one group displays a ‘greater’ association with CHD
over another.
For MI, there was a signiﬁcant association with CMD [model
χ2(17) = 447.07, p< 0.001; block χ2(1) = 10.32, p< 0.001), and
mental disorder groupings [model χ2(22) = 442.72, p < 0.001;
block χ2(6) = 18.41, p = 0.005] after full adjustment. Results
indicate that MADD and Comorbid groupings are associated with
MI; odds were most robust for the Comorbid group (OR: 3.051,
95% CI = 1.74–5.34) followed by the MADD group (OR: 1.54,
95% CI = 1.05–2.26). Again, conﬁdence intervals are overlapping
for Comorbid and MADD groupings, thus we cannot say that
the Comorbid group displays a ‘greater’ association with MI, than
MADD. For coronary revascularisation, there was a signiﬁcant
association with CMD [model χ2(17) = 483.15, p < 0.001; block
χ2(1) = 4.88, p = 0.027], and mental disorder groupings [model
χ2(22) = 479.79, p < 0.001; block χ2(6) = 15.01, p = 0.02]
after full adjustment. Results indicate that the Comorbid group
only is associatedwith coronary revascularisation (OR: 3.087, 95%
CI = 1.67–5.71)
DISCUSSION
The goal of this study was to determine the associations between
CMD, speciﬁc mood and anxiety disorder groupings, and CHD in
a large cohort of participants recruited for the ELSA-Brasil project.
Major ﬁndings highlight a signiﬁcant association between CMD
and CHD (OR: 1.83, 95% CI = 1.53–2.18), even after full adjust-
ment for sociodemographic variables, lifestyle and behavioral
characteristics, and additional risk factors including dyslipidemia,
hypertension, diabetes, and medication use. Further analysis
revealed that this association is most apparent in MDD, GAD,
MADD and comorbid MDD, and anxiety. No signiﬁcant associa-
tions were observed for phobias or PD. The association was most
robust for those with comorbid MDD and anxiety (OR: 2.99, 95%
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Table 1 | Participant characteristics by coronary heart disease (CHD) status1.
Characteristics No CHD (n = 14366, 93%) CHD (n = 721, 7%) Statistic
Age, mean (SD) 51.75 (8.97) 58.71 (8.75) t (15085) = 20.34, p < 0.001
Women (%) 54.9 45.5 χ2(1) = 24.28, p < 0.001
Education (%)
Less than high-school
High-school
College
12.1
34.7
53.2
23.6
33.6
42.9
χ2(2) = 85.03, p < 0.001
Race (%)
White
Mixed
Black
Asiatic
Indigenous
52.4
28.2
15.9
2.5
1.0
50.1
27.1
19.2
2.1
1.6
χ2(4) = 7.76, p = 0.101
Smoker (past or current) (%) 42.5 55.9 χ2(1) = 50.39, p < 0.001
Physical activity
Low
Moderate
High
76.9
13.9
9.2
77.7
16.0
6.3
χ2(2) = 8.59, p = 0.014
Body mass index (kg/m2), mean
(SD)
26.95 (4.74) 28.40 (4.82) t (15079) = 7.99, p < 0.001
Antidepressant status (yes) (%) 6.0 8.7 χ2(1) = 8.39, p = 0.004
Diabetes mellitus (DM; yes) (%) 18.8 37.7 χ2(1) = 156.38, p < 0.001
Hypertension (yes) (%) 34.0 70.0 χ2(1) = 384.40, p < 0.001
Dyslipidemia (yes) (%) 56.9 75.9 χ2(1) = 101.50, p < 0.001
Mental disorder status (%)
No mental disorder
Common mental disorder (CMD)
73.7
26.3
64.8
35.2
χ2(1) = 28.04, p < 0.001
Mental disorder groupings2 (%)
MDD
GAD
Phobias
PD
MADD
Comorbid
1.2
9.9
1.0
0.5
13.0
2.9
2.0
10.2
1.5
0.7
14.6
6.6
χ2(1) = 20.05, p = 0.003
1Some proportions might not add up to 100% due to rounding, and small numbers of participants with missing data. 2Participants categorized into major depressive
disorder (MDD), generalized anxiety disorder (GAD), and panic disorder (PD) did not have additional comorbidity. The Phobias category includes Agoraphobia with
or without panic disorder, Social Phobias and Speciﬁc Phobias. mixed anxiety and depressive disorder (MADD) includes participants who display symptoms of both
anxiety and depression, but do not meet the criteria of either diagnosis separately, while the Comorbid group (comorbid anxiety and depression) includes participants
that meet criteria for MDD and any anxiety disorder.
CI = 2.10–4.28), followed by MDD (OR: 2.14, 95% CI = 1.17–
3.95), MADD (OR: 1.53, 95% CI = 1.1.20–1.94), and GAD (OR:
1.41, 95% CI = 1.07–1.85). Notably, participants with comor-
bid MDD and anxiety disorders display a greater association with
CHD, than GAD and MADD, but not MDD, a speciﬁc ﬁnding
that we discuss further below. Examination of CHD subtypes also
revealed important information; while MDD, GAD, MADD and
comorbid MDD, and anxiety were associated with a signiﬁcant
increase in odds for angina, only those with comorbid MDD and
anxiety disorders and MADD displayed an increase in odds for
MI and coronary revascularisation. In summary, ﬁndings high-
light (1) strong associations between psychiatric comorbidity and
CHD in Brazil, (2) associations for MDD and GAD, in addition to
MADD and the comorbid group, with angina (without a history
of MI or revascularisation), emphasizing the need for close moni-
toring of these individuals to avoid further adverse events, and (3)
that psychiatric comorbidity is associated with MI and coronary
revascularization.
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Table 2 | Participant characteristics by CMD status1.
Characteristics No CMD (n = 11058, 73%) CMD (n = 4036, 27%) p-value
Age, mean (SD) 52.60 (9.22) 50.70 (8.53) t (7703.15) = 11.85, p < 0.001
Women (%) 49.2 68.7 χ2(1) = 451.06, p < 0.001
Education (%)
Less than high-school
High-school
College
12.3
32.0
55.7
14.0
41.7
44.3
χ2(2) = 160.27, p < 0.001
Race (%)
White
Mixed
Black
Asiatic
Indigenous
54.7
26.6
15.0
2.8
0.9
45.3
32.4
19.1
1.8
1.4
χ2(4) = 133.98, p < 0.001
Smoker (past or current) (%) 42.3 45.2 χ2(1) = 10.26, p < 0.001
Physical activity
Low
Moderate
High
74.4
15.3
10.4
84.1
10.3
5.5
χ2(2) = 164.39, p < 0.001
Body mass index (kg/m2), mean (SD) 26.84 (4.61) 27.58 (5.08) t (6602.94) = 8.31, p < 0.001
Antidepressant status (yes) (%) 4.6 10.5 χ2(1) = 180.53, p < 0.001
DM (yes) (%) 19.1 21.2 χ2(1) = 8.078, p = 0.004
Hypertension (yes) (%) 35.7 36.0 χ2(1) = 0.082, p = 0.775
Dyslipidemia (yes) (%) 58.3 56.4 χ2(1) = 4.64, p = 0.031
CHD status (%)
No
Yes
95.8
4.2
93.7
6.3
χ2(1) = 28.04, p < 0.001
1Some proportions might not add up to 100% due to rounding, and small numbers of participants with missing data.
The most robust associations with CHD were observed in those
individuals with psychiatric comorbidity. It is worth noting here
that the combined presence of anxious and depressive symptoms
is associated with more than a twofold increased risk of mortality
in patients with ischemic heart disease (Doering et al., 2010), rel-
ative to those who were free from psychiatric symptoms. We have
previously shown that reduced heart rate variability – a predic-
tor of future mortality – is most reduced in MDD patients with
GAD (Kemp et al., 2012), demonstrating the adverse effects of
distinctive clinical features including a depressive episode, persis-
tent worry, and hypervigilance on cardiac function (see also Kemp
et al., 2014). In the present study, we also observed that only dis-
orders with concurrent anxiety and depression (comorbid MDD
and anxiety, and MADD) also displayed associations with ‘hard’
CHD endpoints including MI and coronary revascularisation.
While our ﬁndings are consistent with studies from high-income
countries (e.g., Vogelzangs et al., 2010), highlighting greater asso-
ciations with comorbid anxiety and depression, our study also
highlights associations with CHD in participants without psychi-
atric comorbidity. In particular, we observed associations between
MDD and GAD, and CHD, further highlighting the importance
of non-comorbid, chronic depression, and generalized anxiety,
rather than disorders involving heightened phasic anxiety (the
phobias and panic disorder). These ﬁndings further suggest that
characteristic features of depression (anhedonia), generalized anx-
iety (anxious apprehension), and psychiatric comorbidity (trait
negative affect) may all contribute to the associations we observed
here in Brazil.
Prior research has indicated that Brazil is a country where
depression (and presumably anxiety) is most often somaticized
(Simon et al., 1999; see also Mari et al., 2013). While this sug-
gests that the associations we observed here may in part, reﬂect
an overlap of somatic symptoms observed in mental illness and
physical disease, the importance of this ﬁnding should not be
minimized. Prognosis for patients with angina is not benign; in
fact, it is no better than those with MI and/or revascularization
(e.g., Buckley and Murphy, 2009). Some limitations of this study
are worth noting here. These include the cross-sectional design
of the study, generalizability of the sample beyond civil servants
in Brazil, and the possibility of undetected or undiagnosed CHD
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Table 4 | Unadjusted (model 1) and adjusted (model 2) associations of mental disorders with CHD.
CHD: model 1a (n = 721) CHD: model 2b (n = 721)
Predictor N OR 95% CI p-value N OR 95% CI p-value
Common mental disorder (CMD)
No CMD 11050 REF 10631 REF
CMD 4026 1.526 1.304–1.787 <0.001 3869 1.829 1.535–2.179 <0.001
Mental disorder groupings
No mental disorder 10405 REF 10012 REF
MDD 179 1.908 1.097–3.320 0.022 170 2.144 1.165–3.945 0.014
Phobias 156 1.540 0.806–2.944 0.191 151 1.555 0.763–3.169 0.224
PD 74 1.630 0.654–4.059 0.845 73 1.433 0.553–3.708 0.459
GAD 1457 1.135 0.877–1.469 0.337 1394 1.405 1.068–1.849 0.015
MADD 1914 1.240 0.992–1.549 0.059 1844 1.528 1.203–1.941 0.001
Comorbid 451 2.492 1.806–3.440 <0.001 434 2.994 2.096–4.275 <0.001
aModel 1 relates to separate unadjusted analyses for CMD and speciﬁc mental disorder groupings including MDD, Phobias, panic disorder (PD), generalized anxiety
disorder (GAD), mixed anxiety and depressive disorder (MADD), and Comorbid MDD and any anxiety disorder. bModel 2 relates to analyses adjusted for sociode-
mographic variables (age, sex, years of education, ethnicity), lifestyle and behavioral characteristics (smoking status, physical activity, body mass index), risk factors
(hypertension, diabetes, dyslipidemia), and medications for lipid reduction, hypertension, diabetes, and mental disorders (antidepressants).
Table 5 | Association between mental disorders and CHD subtypes fully adjusted for sociodemographic variables, lifestyle and behavioral
characteristics, risk factors, and medications.
Angina (n = 305) Myocardial infarction (MI) (n = 259) Coronary revascularisation (n = 239)
Predictor N OR 95% CI p-value N OR 95% CI p-value N OR 95% CI p-value
Common mental disorder (CMD)
No CMD 10358 REF 10634 REF 10635 REF
CMD 3755 2.134 1.671–2.724 <0.001 3877 1.615 1.213–2.151 0.001 3878 1.431 1.048–1.954 0.024
Mental disorder groupings
No mental disorder 9754 REF 10014 REF 10015 REF
MDD 165 2.866 1.359–6.043 0.006 170 2.142 0.818–5.611 0.121 170 0.427 0.057–3.215 0.408
Phobias 146 1.616 0.585–4.469 0.355 152 2.191 0.843–5.696 0.107 152 0.470 0.063–3.490 0.461
PD 71 2.117 0.648–6.914 0.214 73 0.615 0.081–4.653 0.637 73 1.691 0.381–7.503 0.489
GAD 1362 1.588 1.092–2.310 0.015 1395 1.219 0.759–1.957 0.413 1395 1.330 0.818–2.162 0.250
MADD 1795 1.639 1.175–2.286 0.004 1847 1.536 1.045–2.255 0.029 1847 1.447 0.951–2.201 0.084
Comorbid 412 2.976 1.831–4.834 <0.001 436 3.051 1.743–5.342 >0.001 436 3.087 1.668–5.713 <0.001
considering that classiﬁcation of CHD was based on self-report.
The cross-sectional design of the study makes it impossible to
determinewhether themood and anxiety disorders precededCHD
or vice versa. That said, the literature suggests that the relationship
between MDD (and anxiety) and CHD is bidirectional and recip-
rocal (Nemeroff and Goldschmidt-Clermont, 2012; Ramasubbu
et al., 2012a; Stapelberg et al., 2012). We also note that the ELSA-
Brasil cohort captures the racial, social, and regional diversity in
the Brazilian population (see Schmidt et al., 2014), highlighting
the relevance of the present study’s ﬁndings for developing coun-
tries. It is possible, however, that non-diagnosed CHD is lower in
our sample, than for the general Brazilian population, as the civil
servants who participated in our study have more access to health
services. It is possible therefore that the associations we observe
here are lower than those that might be observed in the general
Brazilian population. Indeed, it has been noted previously that
there is a low identiﬁcation rate for depression and other CMDs in
Brazil (Mari et al., 2013; see also Mari et al., 1987; Busnello et al.,
1999).
There are a number of potential explanations for the associ-
ations we observed between the CMD (and speciﬁc diagnostic
groupings) and CHD including psychosocial and biological fac-
tors. Brazil currently faces major social challenges, which may
contribute to chronic stress and increased morbidity (de Jesus
Mari, 2014), strengthening the associations between mental disor-
ders and CHD we observed here, in comparison to high-income
countries. In addition to income inequality (Filho et al., 2013),
personal safety remains an issue of great concern. For example,
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ﬁndings from a representative sample of 15 to 75-year old res-
idents of São Paulo and Rio de Janeiro in Brazil indicated
that psychiatric disorders and traumatic events, especially vio-
lence, are extremely common (Ribeiro et al., 2013). Nearly 90%
of participants surveyed in that study faced a lifetime expo-
sure to actual or threatened death, and these traumatic events
correlated with all psychiatric diagnoses. These results are par-
ticularly relevant in light of other research (Russ et al., 2012)
highlighting a dose-response association between psychologi-
cal distress and increased risk of mortality from a variety of
causes including CVD, cancer and external causes over 8 years.
Biological factors may also underpin associations between the
mood and anxiety disorders and CHD including autonomic
dysfunction, a hyperactive hypothalamic-pituitary-adrenal axis,
increased activity in the sympatho-adreno-medullary activity,
increased inﬂammation, and platelet activation and aggregation
(Nemeroff and Goldschmidt-Clermont, 2012; Ramasubbu et al.,
2012a; Stapelberg et al., 2012; Lichtman et al., 2014). Decreases
in heart rate variability indicative of autonomic dysfunction may
provide a structural link between emotional disturbance and
failure to appropriately regulate inﬂammatory processes leading
to increased morbidity and mortality from a host of disorders
including CVD’s (Kemp and Quintana, 2013). Disturbances in the
immune system may also lead to depression (Dantzer et al., 2008),
highlighting the bidirectional relationships between the mental
disorders, and physical disease.
Our study is characterized by a number of strengths includ-
ing a focus on a relatively large and well-characterized sample
of the Brazilian population, consideration of a variety of speciﬁc
mood and anxiety disorder groupings, application of a structured
clinical interview – rather than self-report – to determine psychi-
atric diagnoses, and adjustment for a host of covariates known
to contribute to metabolic and cardiovascular risk. Recently, we
reported that that use of tricyclic antidepressants is associated
with a twofold increase in prevalent CHD, above and beyond
severity of mood and anxiety symptoms (Kemp et al., 2015).
Importantly, we demonstrate here that the association between
mood and anxiety disorders, and CHD is above and beyond use
of antidepressant medications including tricyclic antidepressants.
A recent statement by the Canadian Network for Mood and Anx-
iety Treatments (CANMAT) task force (Ramasubbu et al., 2012b)
highlights the bidirectional relationship between the mood and
anxiety disorders, and a variety of medical conditions includ-
ing cardiovascular disease, cerebrovascular disease, cancer, human
immuno-deﬁciency virus, hepatitis C virus, migraine, multiple
sclerosis, epilepsy, and osteoporosis. Given the increased risks for
morbidity andmortality associatedwith comorbid psychiatric and
medical conditions, future studies are needed to better understand
the pathways underpinning their comorbidity, with a goal toward
developing more effective preventive strategies and treatments.
Interested readers are referred to recent guidelines for pharmaco-
logical and psychosocial management in low and middle-income
countries (Mari et al., 2013). In conclusion, the present study pro-
vides important new information on the association between the
mental disorders and CHD in Brazil. Findings indicate that the
most robust association with CHD relates to symptomatic and
diagnostic, psychiatric comorbidity, although an association with
MDD and GAD was also observed. Both MDD and GAD were
found to be associated with an increase in the odds for CHD over-
all as well as angina pectoris, which may have adverse implications
for the future health of ELSA-Brasil participants. Considering that
comorbid psychiatric illness and CHD is associated with increased
morbidity andmortality (Lichtman et al., 2014), ﬁndings reinforce
a need for, and the importance of, comprehensive health assess-
ment in Brazil, a country that faces major social challenges and
inequities.
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